Credo AI vs Oximy: Best Platform for AI Governance in 2026?

Oximy describes on-device checks for supported AI requests, files and agent actions, with configured outcomes such as warning, redaction, review or blocking. Its examples include data-sharing restrictions, coding actions and business limits.

That makes the initial buying question concrete: can the proposed deployment apply the enterprise's rule at the relevant step? A company may approve an AI application but prohibit a particular file submission. It may approve a coding agent for development work while requiring review for a production-changing operation.

Ask to see the intended rule operate in the actual supported application. Retain the permitted case as well as the prohibited case, so the evaluator can distinguish a usable control from a general interruption of work. These are proposed acceptance conditions, not reported test results.

Oximy's security review material asks buyers to scope access, administrative evidence, exports and retention. Confirm what is available in the proposed plan rather than assuming every needed governance record follows automatically from a successful local check.

Credo AI's product page describes agent cards, dependency mapping, risk controls, approval gates and production trace evaluation with escalation and remediation. It also labels some CI/CD and API-gateway enforcement integrations as planned. Buyers should establish what is available in the proposed deployment rather than treating every roadmap item as an implemented control.

Its AI adoption material describes a central registry for AI systems, prioritization and communication of use-case value. Adoption and business context are therefore part of its documented scope.

The regulations and standards offering addresses policy and framework mapping. Its audit-artifact material describes governance evidence, decision records and reports.

Evaluate that scope when several functions need to agree whether an AI use case may proceed, under which conditions and with which retained evidence. A formal approval record and a technical action control can support the same program while answering different questions.

A gap in reviewed documentation is a question for the vendor, not proof that the capability cannot exist. Obtain an answer for the proposed modules and environment.

For a multi-vendor replacement shortlist rather than this pairwise decision, use the Credo AI alternatives guide.

Start with the problem that cannot currently be resolved. If legal, security and the business owner disagree about an AI use case's permitted purpose, a successful technical block alone will not settle that disagreement. Someone still needs authority to define the approved use and its conditions.

If those conditions already exist but employees can perform a prohibited action through an uncontrolled path, another approval document does not demonstrate that the action is governed. The evaluation must reach the application, identity and operation where the rule should apply.

For a proposed internal summarization assistant, separate permission to run the use case from permission to submit each type of information. A review might permit public operating procedures but prohibit restricted personnel records. A later request should be evaluated against that boundary, not simply against the assistant's approved status.

Write the two acceptance conditions separately: a responsible owner approves the use case, and the relevant technical path produces the intended outcome. Specify which system holds each record and how a reviewer can connect them.

This approach avoids buying a governance workflow to solve only a local execution problem, or buying a local control while leaving the enterprise's approval process unresolved.

For this purchase, make artificial intelligence governance concrete: identify the approved use case, accountable owner, accepted conditions and point where a condition must affect the work. Ask the governance reviewer and technical operator to agree which system owns each record.

Choose one condition that can be tested, such as read-only access or a restriction on submitted information. Trace it from the approval into the proposed control, then retain the permitted and prohibited results. Keep an unimplemented condition visible rather than closing it because the approval form is complete.

The handoff record below provides a way to compare those responsibilities without assuming that either platform supplies every governance or enforcement function.

The following worksheet is a proposed operating record for evaluating either implementation. It is not a claim that both products provide every field or an integration between them.

Use a stable workflow identifier across the records you intend to join. Do not assume that two systems referring to the same application are describing the same approved use. The purpose, data boundary or agent authority may differ.

Require a named owner for any manual handoff. If an approval must be copied into another system, specify who performs the change, who confirms it and how a later amendment reaches the control. A diagram without an operating responsibility leaves that work unresolved.

The AI risk-assessment guide helps structure the assessment. The handoff record here connects its conditions to an execution test and an accountable review.

Consider a proposed procurement assistant that summarizes synthetic supplier documents. The initial approval permits draft analysis, but not autonomous supplier selection or submission of restricted contract terms to an unapproved destination. This is an illustrative evaluation exercise, not a customer story.

First, have the business owner describe the approved task and its output. Give the security reviewer a synthetic permitted document and a synthetic document containing a restricted field. Record which input, destination and operation the policy should accept or restrict.

Next, ask the evaluator to demonstrate both cases through the intended application. If review is required, identify the approver and the information available to that person. A message saying that review is required does not establish whether execution actually waits for approval.

Then propose a change: the assistant receives a tool that can submit a supplier decision. The governance owner should determine whether that changes the approved use. The technical evaluator should determine whether the new operation is covered by the configured control.

Keep those decisions separate in the record. An approved summarization task should not silently become approval for a transaction. Conversely, a technical restriction should not be represented as a completed legal or procurement assessment.

Finally, inspect the retained evidence with someone who did not run the demonstration. Ask that reviewer to identify the approved purpose, the changed authority, the observed control outcome and what remains unresolved.

For any proposed control, distinguish observing an event, evaluating it, interrupting it and escalating it to a person. Those outcomes may support different requirements.

A review that occurs after a completed action can support investigation, but it does not establish prevention. An approval gate can restrict deployment, but that alone does not demonstrate control over every later tool call. A prevented action also does not prove that a central registry contains every relevant AI system.

Credo's current product documentation includes production monitoring while identifying some integrations as planned. Request a current availability statement and demonstration for the exact control in the proposal. Do not convert either broad marketing language or a planned item into a blanket conclusion about the entire platform.

For Oximy, ask the same deployment-specific question about the supported application and action. Record whether the control is preventive, advisory, approval-based or detective, and what happens when a required component is unavailable.

If network-mediated policy is part of the architecture, the WitnessAI vs Oximy comparison examines that control path. For agent permissions and runtime coverage, see Zenity vs Oximy.

Credo's artifact offering is relevant when governance teams need decision documentation and reports. Oximy's security review identifies evidence access, policy changes, exports and retention as scope questions.

For either proposal, ask an authorized reviewer to reconstruct one decision using only the proposed retained records. The reviewer should be able to distinguish a policy requirement, an assessment result, a human approval and an observed execution outcome.

Also inspect who can change or delete those records, how corrections are represented and whether the evidence survives a change in the employee or system owner. Where records stay in another authoritative system, document that dependency instead of assuming everything must be copied.

Evidence software does not, by itself, provide an independent audit opinion. Ask the audit or assurance owner what criteria apply and what additional work is required. A framework mapping is similarly not a conclusion that every legal obligation has been satisfied.

For enterprises comparing evidence systems more broadly, the AI governance audit-tools guide separates software capabilities from independent assurance.

Make the exception process specific to the disputed decision. A business owner can explain why a workflow is needed, but may not be authorized to approve disclosure of restricted information. Security and privacy reviewers should know when the request exceeds their delegated authority.

A proposed exception record should state the affected workflow, allowed action, conditions, approver and expiry. Ask which fields the selected product supports and which must remain in the enterprise's existing governance or ticketing process.

After security acceptance, the CIO and workflow owner can assess whether approved use produces useful completed work. Choose a baseline, quality measure and observation window before describing a business benefit. Track the effort needed to administer policies and resolve interruptions as part of that review.

Neither a count of approvals nor a count of blocked actions establishes financial return. Equally, an apparently productive workflow does not erase an unresolved security condition.

If the assessment depends on discovering sensitive data and understanding access across repositories, Cyera vs Oximy addresses that adjacent purchase decision.

If the purchase changes an existing approval or control process, identify the records that must remain available. A replacement should not depend on staff remembering why an earlier exception was accepted.

Before transition, select one approved use case, one rejected request and one active exception. Ask the evaluator to show how the proposed deployment represents their current status and the evidence behind it. Where history remains in another system, retain the reference and confirm that the reviewer can still access it.

Define what happens to open reviews during the change. Assign an owner to reconcile duplicate records, unresolved approvals and controls that have not yet been tested in the new path. Keep the existing restriction in place until the replacement meets the enterprise's acceptance conditions.

Also request an exit procedure for the new deployment. Establish what can be exported, in which form, by whom and under which commercial terms. These are procurement questions, not assertions that either vendor supplies a particular migration tool or export format.

This exercise helps separate the value of a new capability from the risk and work of replacing a process that already holds governance decisions.

Oximy's public pricing lists $10 per device per month or $100 per device per year for self-serve use, with custom pricing for larger deployments. That is a list price, not a quoted enterprise implementation.

The reviewed Credo AI product and get-started pages do not provide a numerical enterprise rate. Request a current proposal that identifies the required capabilities, implementation work, support and evidence requirements.

Compare the same agreed scope. A device-policy deployment and a broader governance-program deployment may have different responsibilities and operating costs. Missing public pricing does not demonstrate a cost disadvantage.

Have procurement separate required scope from optional consolidation. Establish what the enterprise must retain in its existing systems and what work the proposed product actually removes before making a replacement decision.

Book an Oximy demo with one workflow, its approved data or action boundary, and the evidence your reviewer needs. Ask to see the supported control path and what remains outside it.

1. 01Credo AICredo AIVendor-published
2. 02AI adoption materialCredo AIVendor-published
3. 03regulations and standards offeringCredo AIVendor-published
4. 04audit-artifact materialCredo AIVendor-published
5. 05get-started pagesCredo AIVendor-published